Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
N414294-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$118.90
|
|
|
N414294-5mg
|
5mg |
3
|
$414.90
|
|
|
N414294-10mg
|
10mg |
3
|
$622.90
|
|
|
N414294-25mg
|
25mg |
2
|
$806.90
|
|
|
N414294-50mg
|
50mg |
2
|
$989.90
|
|
IDO/TDO Inhibitors
| Synonyms | NLG-919 | NLG-919 Navoximod | US10233190, Example 1484 | F85292 | (1R,4r)-4-((R)-2-((S)-6-fluoro-5H-imidazo[5,1- a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol | Navoximod | Navoximod;GDC-0919;IDO-IN-7;NLG-1488 | NAVOXIMOD [INN] | NLG-?919 | UNII-926SHL95NC |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | Navoximod (GDC-0919, NLG-919) is a potent inhibitor of IDO (indoleamine-(2,3)-dioxygenase) pathway with Ki of 7 nM and EC50 of 75 nM. |
| Storage Temp | Store at -20°C,Argon charged |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information Navoximod Navoximod (GDC-0919, NLG-919) is a potent inhibitor of IDO (indoleamine-(2,3)-dioxygenase) pathway with Ki of 7 nM and EC50 of 75 nM. Targets IDO (Cell-free assay); IDO (Cell-free assay) 7 nM(Ki); 75 nM(EC50) In vitro NLG919 potently blocks IDO-induced T-cell suppression and restored robust T-cell responses with ED50 of 80 nM. Similarly, using IDO-expressing mouse DCs from tumor-draining lymph nodes, NLG919 abrogated IDO-induced suppression of antigen-specific T cells (OT-I) with ED50 of 120 nM.\xa0NLG919 increases the cytotoxic activity of paclitaxel toward B16-F10 cells in the presence of pretreatment with interferon (IFN)-γ in vitro. In vivo In mice, a single oral administration of NLG919 reduces the concentration of plasma and tissue Kyn by ~ 50%. In mice bearing B16F10 tumors, NLG919 markedly enhances the antitumor responses of naive, resting pmel-1 cells to vaccination with cognate hgp100 peptide plus CpG-1826 in IFA.Immune competent mice are injected orthotopically with genetically engineered murine glioma cells and treated with GDC-0919 alone or combined with RT. GDC-0919 demonstrates potent inhibition of this node and effectively crosses the blood brain barrier. Although GDC-0919 as a single agent does not demonstrate anti-tumor activity, it has a strong potential for enhancing RT response in glioblastoma, which is further augmented with a hypofractionated regimen. Cell Research(from reference) Cell lines:the murine melanoma cell line B16-F10 Concentrations:100\u2009nM Incubation Time:12\u2009h, 24\u2009h, 48\u2009h, 72\u2009h |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Isoindoles and derivatives |
| Subclass | Isoindoles |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Isoindoles |
| Alternative Parents | Cyclohexanols N-substituted imidazoles Benzenoids Aryl fluorides Heteroaromatic compounds Cyclic alcohols and derivatives Azacyclic compounds Organopnictogen compounds Organonitrogen compounds Organofluorides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Isoindole - Cyclohexanol - Benzenoid - N-substituted imidazole - Aryl halide - Aryl fluoride - Heteroaromatic compound - Imidazole - Cyclic alcohol - Azole - Secondary alcohol - Azacycle - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organofluoride - Organohalogen compound - Alcohol - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as isoindoles. These are heteropolycyclic compounds with a structure containing isoindole, a benzo-fused pyrrole. |
| External Descriptors | Not available |
|
|
|
| ALogP | 2.224 |
|---|---|
| hba_count | 1 |
| HBD Count | 2 |
| Rotatable Bond | 3 |
| Pubchem Sid | 504771996 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504771996 |
| IUPAC Name | 4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol |
| INCHI | InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m0/s1 |
| InChIKey | YGACXVRLDHEXKY-LHPNLFKDSA-N |
| Smiles | C1CC(CCC1C(CC2C3=C(C=CC=C3F)C4=CN=CN24)O)O |
| Isomeric SMILES | C1CC(CCC1[C@@H](C[C@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O |
| Molecular Weight | 316.37 |
| Reaxy-Rn | 30199924 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30199924&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 09, 2025 | N414294 | |
| Certificate of Analysis | Jun 09, 2025 | N414294 | |
| Certificate of Analysis | Jun 09, 2025 | N414294 | |
| Certificate of Analysis | Jun 09, 2025 | N414294 | |
| Certificate of Analysis | Jun 15, 2022 | N414294 |
| Solubility | Solubility (25°C) In vitro DMSO: 63 mg/mL (199.13 mM); Ethanol: 63 mg/mL (199.13 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 63 |
| DMSO(mM) Max Solubility | 199.133925467016 |
| Water(mg / mL) Max Solubility | <1 |
| Molecular Weight | 316.400 g/mol |
| XLogP3 | 2.100 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 316.159 Da |
| Monoisotopic Mass | 316.159 Da |
| Topological Polar Surface Area | 58.300 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 416.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |